Key Highlights
Medicine · Diabetes
This comprehensive review systematically examines the cardiovascular–kidney–metabolic (CKM) syndrome, a newly conceptualized entity that integrates interconnected pathophysiological mechanisms across cardiorenal and metabolic systems. The authors present detailed epidemiological data highlighting the rising global burden of CKM syndrome, alongside updated diagnostic criteria and evidence-based management strategies encompassing lifestyle, pharmacotherapy, and multidisciplinary care. For a diabetologist leading clinical care and standards in India, this synthesis offers a crucial framework for understanding the overlapping complications of diabetes, kidney disease, and cardiovascular risk, directly informing integrated patient management and policy advocacy.
Novelty: 88%
Rigor: 94%
Significance: 92%
Validity: 95%
Clarity: 90%
Medicine · Diabetes & Endocrinology
This correspondence addresses critical feedback regarding the inclusion of analogue insulin and GLP-1 receptor agonists on the WHO Model Essential Medicines List, emphasizing the importance of equitable access to advanced diabetes therapies worldwide. The authors reaffirm their position that updated essential medicines listings can accelerate global availability of these agents, particularly in low- and middle-income settings. For a clinical leader and national advocate in India, this discussion is directly relevant to ongoing efforts to expand access to modern diabetes pharmacotherapies and shape treatment guidelines across resource-constrained populations.
Novelty: 72%
Rigor: 85%
Significance: 80%
Validity: 88%
Clarity: 95%
Update Your Briefing Preferences
Stay curious. Stay informed —
Science Briefing
Your briefing is personalized based on your selected fields, keywords, and research interests.
